CD 129 (Ranitidine Hydrochloride 150 mg)
Pill with imprint CD 129 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Dr. Reddy’s Laboratories Inc..
Ranitidine is used in the treatment of duodenal ulcer; gerd; erosive esophagitis; cutaneous mastocytosis; duodenal ulcer prophylaxis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CD 129
Ranitidine Hydrochloride
- Imprint
- CD 129
- Strength
- 150 mg
- Color
- Brown
- Size
- 15.00 mm
- Shape
- Capsule-shape
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy’s Laboratories Inc.
- Inactive Ingredients
-
magnesium stearate,
microcrystalline cellulose,
sodium starch glycolate type A potato,
ferrosoferric oxide,
ferric oxide red,
ferric oxide yellow,
titanium dioxide,
gelatin
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 55111-0129 | Dr. Reddy's Laboratories, Inc. |
| 42291-0735 | AvKare, Inc. |
More about ranitidine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- En Español
- 152 Reviews
- Drug class: H2 antagonists
- FDA Alerts (18)
Consumer resources
- Other brands
- Zantac
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.